Literature DB >> 28236126

Imminent fracture risk.

C Roux1,2,3, K Briot4,5.   

Abstract

The clinical significance of osteoporosis is in the occurrence of fractures and re-fractures. The main risk factor of sustaining a fracture is a previous one, but a recent fracture is a better fracture risk factor than fracture history. The role of the recency of fracture has been shown for both vertebral and non-vertebral fracture risk. This imminent risk is explained by both bone-related factors (underlying osteoporosis) and fall-related factors (including those related to postfracture care). Such a short-term increased risk has been shown also in patients initiating corticosteroids and in frail osteoporotic subjects with central nervous system (CNS) diseases or drugs targeting CNS, and thus a high risk of falls. Patients with an imminent (i.e. 2 years) risk of fracture or refracture should be identified in priority in order to receive an immediate treatment and a program of fall prevention.

Entities:  

Keywords:  Fracture; Imminent; Osteoporosis; Treatment

Mesh:

Year:  2017        PMID: 28236126     DOI: 10.1007/s00198-017-3976-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

1.  Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study.

Authors:  John T Schousboe; Howard A Fink; Brent C Taylor; Katie L Stone; Teresa A Hillier; Michael C Nevitt; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2004-10-25       Impact factor: 6.741

2.  Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Authors:  Tahir Masud; Neil Binkley; Steven Boonen; Marian T Hannan
Journal:  J Clin Densitom       Date:  2011 Jul-Sep       Impact factor: 2.617

Review 3.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

4.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

5.  Imminent risk of fracture after fracture.

Authors:  H Johansson; K Siggeirsdóttir; N C Harvey; A Odén; V Gudnason; E McCloskey; G Sigurdsson; J A Kanis
Journal:  Osteoporos Int       Date:  2016-12-27       Impact factor: 4.507

6.  Subsequent fracture in nursing home residents with a hip fracture: a competing risks approach.

Authors:  Sarah D Berry; Elizabeth J Samelson; Long Ngo; Malynda Bordes; Kerry E Broe; Douglas P Kiel
Journal:  J Am Geriatr Soc       Date:  2008-08-21       Impact factor: 5.562

7.  Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample.

Authors:  Harpreet S Bawa; Jack Weick; Douglas R Dirschl
Journal:  J Bone Joint Surg Am       Date:  2015-10-07       Impact factor: 5.284

Review 8.  The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials.

Authors:  Fabienne El-Khoury; Bernard Cassou; Marie-Aline Charles; Patricia Dargent-Molina
Journal:  BMJ       Date:  2013-10-29

9.  Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views.

Authors:  Sophie Alami; Lucile Hervouet; Serge Poiraudeau; Karine Briot; Christian Roux
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

10.  Patterns of Prescription Drug Use Before and After Fragility Fracture.

Authors:  Jeffrey C Munson; Julie P W Bynum; John-Erik Bell; Robert Cantu; Christine McDonough; Qianfei Wang; Tor D Tosteson; Anna N A Tosteson
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

View more
  41 in total

Review 1.  Current Status of Bone-Forming Therapies for the Management of Osteoporosis.

Authors:  Anne Sophie Koldkjær Sølling; Torben Harsløf; Bente Langdahl
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 2.  Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

Authors:  G Adami; K G Saag
Journal:  Osteoporos Int       Date:  2019-02-25       Impact factor: 4.507

3.  The Predictive Value of Sarcopenia and Falls for 2-Year Major Osteoporotic Fractures in Community-Dwelling Older Adults.

Authors:  Yi Su; Freddy M H Lam; Jason Leung; Wing-Hoi Cheung; Suzanne C Ho; Timothy Kwok
Journal:  Calcif Tissue Int       Date:  2020-05-30       Impact factor: 4.333

Review 4.  [Influence of hormone or hormone replacement therapy on bone healing].

Authors:  Friederike Thomasius; Peyman Hadji
Journal:  Unfallchirurg       Date:  2019-07       Impact factor: 1.000

5.  FRAX: a coming of age.

Authors:  W D Leslie
Journal:  Osteoporos Int       Date:  2018-09-25       Impact factor: 4.507

6.  Drinking tea before menopause is associated with higher bone mineral density in postmenopausal women.

Authors:  Saili Ni; Lu Wang; Guowei Wang; Jie Lin; Yiyun Ma; Xueyin Zhao; Yuan Ru; Weifang Zheng; Xiaohui Zhang; Shankuan Zhu
Journal:  Eur J Clin Nutr       Date:  2021-01-29       Impact factor: 4.016

Review 7.  Sexual Dimorphism and the Origins of Human Spinal Health.

Authors:  Vicente Gilsanz; Tishya A L Wren; Skorn Ponrartana; Stefano Mora; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 8.  Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?

Authors:  Felicia Cosman; David W Dempster
Journal:  Curr Osteoporos Rep       Date:  2021-02-26       Impact factor: 5.096

Review 9.  Approaches to Fracture Risk Assessment and Prevention.

Authors:  Sanford Baim; Robert Blank
Journal:  Curr Osteoporos Rep       Date:  2021-02-01       Impact factor: 5.096

Review 10.  [German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version].

Authors:  Jan Leipe; Julia U Holle; Christiane Weseloh; Alexander Pfeil; Klaus Krüger
Journal:  Z Rheumatol       Date:  2021-08-06       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.